{
    "organizations": [],
    "uuid": "46e53dd2dd92b80ac539289f2cc18683c4d137c0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shenzhen-salubris-pharmaceuticals/brief-shenzhen-salubris-pharmaceuticals-posts-10-3-pct-rise-q1-net-profit-idUSH9N1RO02C",
    "ord_in_thread": 0,
    "title": "BRIEF-Shenzhen Salubris Pharmaceuticals Posts 10.3 Pct Rise Q1 Net Profit",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16 (Reuters) - Shenzhen Salubris Pharmaceuticals Co Ltd:\n* SAYS Q1 NET PROFIT UP 10.3 PERCENT Y/Y AT 415.3 MILLION YUAN ($66.14 million) Source text in Chinese: bit.ly/2J0kV0C Further company coverage: ($1 = 6.2795 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-04-16T21:06:00.000+03:00",
    "crawled": "2018-04-17T12:21:21.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "shenzhen",
        "salubris",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "q1",
        "net",
        "profit",
        "percent",
        "million",
        "yuan",
        "million",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}